NO874892L - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.

Info

Publication number
NO874892L
NO874892L NO874892A NO874892A NO874892L NO 874892 L NO874892 L NO 874892L NO 874892 A NO874892 A NO 874892A NO 874892 A NO874892 A NO 874892A NO 874892 L NO874892 L NO 874892L
Authority
NO
Norway
Prior art keywords
butyl
pyrrole
formula
compound
hydroxybenzoyl
Prior art date
Application number
NO874892A
Other languages
English (en)
Norwegian (no)
Other versions
NO874892D0 (no
Inventor
Joseph M Muchowski
Robert J Greenhouse
John M Young
D V Krishna Murthy
Brian H Vickery
Keith A M Walker
Ruei-Chen Chin
Anthony Prince
Moysey M Povzhitkov
John O Gardner
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO874892D0 publication Critical patent/NO874892D0/no
Publication of NO874892L publication Critical patent/NO874892L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO874892A 1986-11-25 1987-11-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger. NO874892L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/936,551 US4833155A (en) 1986-11-25 1986-11-25 3-(ω-(3,5,-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles, and anti-inflammatory uses thereof

Publications (2)

Publication Number Publication Date
NO874892D0 NO874892D0 (no) 1987-11-24
NO874892L true NO874892L (no) 1988-06-17

Family

ID=25468795

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874892A NO874892L (no) 1986-11-25 1987-11-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.

Country Status (13)

Country Link
US (1) US4833155A (fr)
EP (1) EP0269981A1 (fr)
JP (1) JPS63154658A (fr)
KR (1) KR880006191A (fr)
AU (1) AU8164287A (fr)
DK (1) DK617487A (fr)
FI (1) FI875184A (fr)
HU (2) HU201010B (fr)
IL (1) IL84577A0 (fr)
NO (1) NO874892L (fr)
PH (1) PH24245A (fr)
PT (1) PT86205B (fr)
ZA (1) ZA878812B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234937A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents
US5086064A (en) * 1990-03-27 1992-02-04 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxyphenyl thiazolyl, oxazolyl, and imidazolyl methanones and related compounds as antiinflammatory agents
US5102897A (en) * 1990-03-27 1992-04-07 Warner-Lambert Company 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues
US5234939A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxyphenyl imidazolyl methanones and related compounds as antiinflammatory agents
FR2669029B1 (fr) * 1990-11-14 1994-09-02 Adir Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5684204A (en) * 1995-11-15 1997-11-04 The Procter & Gamble Company Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
AP1390A (en) * 1996-11-27 2005-04-15 Aventis Pharmaceuticals Products Inc Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound.
US7479507B2 (en) * 2003-01-14 2009-01-20 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
EP1582531A1 (fr) 2004-03-24 2005-10-05 Aventis Pharma S.A. Procédé d'oxydation d'héparines non-fractionnées et la détection de la présence ou de l'absence de glycosérine dans l'héparine et les produits dérivés de l'héparine.
EP2084142B1 (fr) 2006-10-17 2016-03-23 SI Group, Inc. Produits de réaction hétérocycliques alkylés convenant comme anti-oxydants
FR2934998B1 (fr) * 2008-08-12 2010-09-03 Robert Vachy Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes
EP4182452A4 (fr) 2020-07-14 2024-07-31 Optimvia Llc Procédés de synthèse de sulfate d'héparane non anticoagulant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644631A (en) * 1969-05-13 1972-02-22 Endo Lab Therapeutic methods utilizing aryl pyrrol-3-yl ketones
US4000160A (en) * 1973-04-11 1976-12-28 Sterling Drug Inc. Pyrrolyl oxyphenyl ketones
US4124725A (en) * 1977-05-16 1978-11-07 Riker Laboratories, Inc. Anti-inflammatory method
US4418074A (en) * 1981-11-23 1983-11-29 Riker Laboratories, Inc. 2,6 Di(t-butyl)-4-(2'-pyrrol)-phenol and anti-inflammatory use thereof

Also Published As

Publication number Publication date
ZA878812B (en) 1989-06-28
PT86205B (pt) 1990-11-07
US4833155A (en) 1989-05-23
DK617487A (da) 1988-05-26
FI875184A (fi) 1988-05-26
IL84577A0 (en) 1988-04-29
KR880006191A (ko) 1988-07-22
FI875184A0 (fi) 1987-11-24
AU8164287A (en) 1988-05-26
NO874892D0 (no) 1987-11-24
PT86205A (en) 1987-12-01
EP0269981A1 (fr) 1988-06-08
HU201010B (en) 1990-09-28
PH24245A (en) 1990-05-04
HUT47904A (en) 1989-04-28
JPS63154658A (ja) 1988-06-27
DK617487D0 (da) 1987-11-24
HUT46303A (en) 1988-10-28

Similar Documents

Publication Publication Date Title
NO874892L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
Sujith et al. Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety
EP1071648A2 (fr) Acides carboxyliques et acylsulfonamides, compositions contenant ces composes et methodes de traitement
DK162524B (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
NO152091B (no) Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-difenylthiofener
US6242493B1 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
JP4434745B2 (ja) 複素環式アリールスルホンアミドベンジル化合物
HU185430B (en) Process for producing 6-chloro- or 6-bromol-1,2-dyhidro-3h-pyrrolo-bracket-1,2-a-bracket closed-pyrrole-1-cerboxylic acid derivatives
JP2005516042A (ja) アリールスルホンアミドベンジル化合物
US4272507A (en) Phenylaminothiophenacetic acids, their synthesis, compositions and use
EP0033614A1 (fr) Dérivés de l'acide phénylalcanique, procédés pour leur préparation et composés pharmaceutiques contenant ceux-ci
EP0005156B1 (fr) 4,5-Diaryl-2-(thio-substitué)-pyrroles et leurs sulfoxydes et sulfones correspondants, procédé pour leur préparation et composition pharmaceutique les contenant
KR100303377B1 (ko) 신규피롤유도체
L Khokra et al. Rational Design and Synthesis of Biologically Active Disubstituted 2 (3H) Furanones and Pyrrolone Derivatives as Potent and Safer Non Steroidal Anti-inflammatory Agents
EP1590324B1 (fr) NOUVEAUX DERIVES D'ACETONE A SUBSTITUTION HETEROARYLE SERVANT D'INHIBITEURS DE PHOSPHOLIPASE A sb 2 /sb
US6936632B2 (en) Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
AU756333B2 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
KR20000070487A (ko) 5-아로일나프탈렌 유도체
US4935440A (en) 3-[ω-(3,5-Di-t-butyl-4-hydroxyphenyl)alkyl]pyrroles, and anti-inflammatory uses thereof
NO853694L (no) Vinyltetrazolylfenylderivater, fremstilling og anvendelse derav.
JP2009511437A (ja) Ｐｐａｒ作動薬ｉとしてのチオフェン誘導体
US4165383A (en) Anti-inflammatory method
NO823586L (no) Fenolderivater.
JPS6011440A (ja) 新ベンゾフエノン
IE60102B1 (en) New derivatives of 1-styrenesulphonyl-2-oxo-5-hydroxy pyrrolidine, the process and the intermediates for their preparation, their application as medicaments and the compositions containing them